HU9401936D0 - Process and uses for 4,5-diohydrogeldanamycin and its hydroquinone - Google Patents

Process and uses for 4,5-diohydrogeldanamycin and its hydroquinone

Info

Publication number
HU9401936D0
HU9401936D0 HU9401936A HU9401936A HU9401936D0 HU 9401936 D0 HU9401936 D0 HU 9401936D0 HU 9401936 A HU9401936 A HU 9401936A HU 9401936 A HU9401936 A HU 9401936A HU 9401936 D0 HU9401936 D0 HU 9401936D0
Authority
HU
Hungary
Prior art keywords
diohydrogeldanamycin
hydroquinone
Prior art date
Application number
HU9401936A
Other languages
Hungarian (hu)
Inventor
Mark T Jefferson
Walter P Cullen
Mikel P Moyer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU9401936D0 publication Critical patent/HU9401936D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HU9401936A 1992-01-06 1992-12-03 Process and uses for 4,5-diohydrogeldanamycin and its hydroquinone HU9401936D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81723592A 1992-01-06 1992-01-06

Publications (1)

Publication Number Publication Date
HU9401936D0 true HU9401936D0 (en) 1994-09-28

Family

ID=25222638

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401936A HU9401936D0 (en) 1992-01-06 1992-12-03 Process and uses for 4,5-diohydrogeldanamycin and its hydroquinone

Country Status (15)

Country Link
JP (1) JPH06510913A (en)
KR (1) KR940703923A (en)
CN (1) CN1074937A (en)
AU (1) AU3225693A (en)
BR (1) BR9207024A (en)
CA (1) CA2127457A1 (en)
CZ (1) CZ390592A3 (en)
FI (1) FI943207A0 (en)
HU (1) HU9401936D0 (en)
IL (1) IL104289A0 (en)
MX (1) MX9300011A (en)
NO (1) NO942532L (en)
PT (1) PT101169A (en)
WO (1) WO1993014215A1 (en)
ZA (1) ZA9333B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001342A1 (en) * 1993-06-29 1995-01-12 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1435939B1 (en) 2001-09-24 2008-02-27 Conforma Therapeutic Corporation Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
EP1923061A1 (en) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
JP2005530689A (en) 2002-02-08 2005-10-13 コンフォーマ・セラピューティクス・コーポレイション Ansamycins with improved pharmacological and biological properties
TW200303363A (en) * 2002-02-25 2003-09-01 Upjohn Co Process to prepare and isolate geldanamycin
WO2005009345A2 (en) 2003-06-13 2005-02-03 Kosan Biosciences, Inc. 2-desmethyl ansamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6870049B1 (en) 2003-11-12 2005-03-22 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
EP1689436A1 (en) * 2003-11-26 2006-08-16 Entelos, Inc. TREATMENT OF RHEUMATOID ARTHRITIS WITH HYPOXIA-INDUCIBLE FACTOR a ANTAGONISTS
US7282493B2 (en) 2003-12-23 2007-10-16 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
CN1898212B (en) * 2003-12-23 2012-06-13 无限发现公司 Analogs of benzoquinone-containing ansamycins for the treatment of cancer
AU2006230447A1 (en) 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
US8492370B2 (en) * 2006-11-09 2013-07-23 Bristol-Myers Squibb Company Compounds and methods for their production
PE20081506A1 (en) 2006-12-12 2008-12-09 Infinity Discovery Inc ANSAMYCIN FORMULATIONS
CN100500668C (en) * 2006-12-19 2009-06-17 中国人民解放军军事医学科学院毒物药物研究所 Geldanamycin derivative and its preparing method and use for preparing medicine
JP2010516282A (en) 2007-01-26 2010-05-20 コーサン バイオサイエンシーズ， インコーポレイテッド Macrolactam by engineering biosynthesis
US20110034686A1 (en) * 2008-04-21 2011-02-10 Nitin Sopanrao Patil Process for Isolation and Purification of Geldanamycin
US8778921B2 (en) 2008-10-15 2014-07-15 Infinity Pharmaceuticals, Inc. Ansamycin hydroquinone compositions
CN102030764B (en) * 2010-11-12 2012-07-04 中国医学科学院医药生物技术研究所 4,5-dihydro-thiazinogeldanamycin and preparation method thereof
CN103305563B (en) * 2013-06-14 2014-12-03 湖南农业大学 Method for extracting alisamycin from streptomyces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same

Also Published As

Publication number Publication date
AU3225693A (en) 1993-08-03
WO1993014215A1 (en) 1993-07-22
NO942532D0 (en) 1994-07-05
CN1074937A (en) 1993-08-04
ZA9333B (en) 1994-07-05
CZ390592A3 (en) 1993-08-11
IL104289A0 (en) 1993-05-13
CA2127457A1 (en) 1993-07-22
BR9207024A (en) 1995-12-05
MX9300011A (en) 1993-12-01
JPH06510913A (en) 1994-12-08
FI943207A (en) 1994-07-05
KR940703923A (en) 1994-12-12
PT101169A (en) 1994-03-31
FI943207A0 (en) 1994-07-05
NO942532L (en) 1994-07-05

Similar Documents

Publication Publication Date Title
IL104289A0 (en) Process and uses for 4,5-dihydrogel-danamycin and its hydroquinone
EP0589675A3 (en) BiCDMOS process technology and structures.
ZA938826B (en) Process
GB9218346D0 (en) Process
GB9203375D0 (en) Process
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
SG73396A1 (en) Hydrotrating process
GB9202375D0 (en) Process
AP9300474A0 (en) Process
IL105168A0 (en) Heteroannulation process
GB9220068D0 (en) Process
ZA939517B (en) Process
GB9301275D0 (en) Process
GB9215438D0 (en) Process
IL104302A0 (en) Process
GB9225202D0 (en) Process
GB9220526D0 (en) Process
GB9301562D0 (en) Process
GB9216664D0 (en) Novel compounds and process
GB9216662D0 (en) Novel compounds and process
GB9225373D0 (en) Novel compounds and process
GB9211841D0 (en) Dehydregenation process
GB9203372D0 (en) Process
GB9215904D0 (en) Process
GB9209833D0 (en) Process